Invention Grant
- Patent Title: Vasopressin formulations for use in treatment of hypotension
-
Application No.: US15688326Application Date: 2017-08-28
-
Publication No.: US10010575B2Publication Date: 2018-07-03
- Inventor: Matthew Kenney , Vinayagam Kannan , Sunil Vandse , Suketu Sanghvi
- Applicant: Par Pharmaceutical, Inc.
- Applicant Address: US NY Chestnut Ridge
- Assignee: Par Pharmaceutical, Inc.
- Current Assignee: Par Pharmaceutical, Inc.
- Current Assignee Address: US NY Chestnut Ridge
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K38/11
- IPC: A61K38/11 ; A61K47/12 ; A61K47/10 ; A61K9/08 ; A61K31/045 ; G01N30/74 ; A61K9/00 ; G01N30/02
Abstract:
Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
Public/Granted literature
- US20180000890A1 VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION Public/Granted day:2018-01-04
Information query
